Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial


Por: Cai, AP, Bayes-Genis, A, Ryan, J, Feng, YQ, Januzzi, JL, Tonkin, AM, Zheng, JZ, Nelson, MR, Neumann, JT, Woods, RL, Tran, C, Schutte, AE, Pandey, A, Chen, LY, Liu, L, Zhang, JG, Mcneil, JJ, Beilin, L, Tes, HF, Parati, G and Zhou, Z

Publicada: 9 dic 2025 Ahead of Print: 22 oct 2025
Resumen:
BACKGROUND: Blood pressure (BP) management in older adults is complex because of age-related physiological changes and uncertainty around ideal systolic BP (SBP) targets. Heart stress (HS), defined by age-adjusted elevation in NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels, may improve cardiovascular disease (CVD) risk stratification and support more individualized BP management. METHODS: We conducted a post hoc analysis of ASPREE (Aspirin in Reducing Events in the Elderly) involving 11 941 community-dwelling older adults without CVD at enrollment (mean age, 75.1 years; 53.5% women). HS was defined by NT-proBNP >= 150 pg/mL for participants 65 to 74 years of age and >= 300 pg/mL for participants >= 75 years of age. Participants were categorized into 4 groups by hypertension and HS status. The primary outcome was total CVD events (a composite of nonfatal myocardial infarction, fatal or nonfatal stroke, coronary heart disease death, or hospitalization for heart failure). Associations between hypertension and SBP with total CVD events were examined by HS status using Cox proportional-hazards models and restricted cubic spline. SBP was evaluated categorically (<120, 120-129, 130-139, 140-159, or >= 160 mm Hg) and continuously. A landmark sensitivity analysis excluded participants with CVD events or censoring in the first 2 years, with follow-up starting at year 3. RESULTS: HS was present in 25.8% of participants. Compared with the reference group (no hypertension or HS), adjusted hazard ratios (95% CI) for total CVD events were 1.41 (1.18-1.70) for hypertension + no HS, 1.79 (1.34-2.39) for no hypertension + HS, and 2.32 (1.89-2.84) for hypertension + HS (P-trend<0.001). Among participants without HS, the lowest incidence of total CVD events occurred at SBP 130 to 139 mm Hg, showing a U-shaped association across SBP levels (P-non(linearity)=0.011). Among participants with HS, risk increased linearly with SBP (P-linear (trend)=0.85) and was lowest at SBP <120 mm Hg. Landmark analyses yielded generally consistent findings. CONCLUSIONS: HS is common in older adults and jointly associated with hypertension and increased CVD risk. The SBP-CVD relationship differs by HS status, suggesting a potential value of HS for guiding individualized BP management. Prospective studies are warranted to determine whether HS-guided strategies improve BP control and reduce CVD risk in older adults.

Filiaciones:
Cai, AP:
 Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Hypertens Res Lab, Dept Cardiol,Guangdong Cardiovasc Inst, Guangzhou, Peoples R China

:
 Hosp Univ Germans Trias i Pujol, Heart Inst, CIBERCV, Badalona, Spain

Ryan, J:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

Feng, YQ:
 Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Hypertens Res Lab, Dept Cardiol,Guangdong Cardiovasc Inst, Guangzhou, Peoples R China

Januzzi, JL:
 Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA USA

 Baim Inst Clin Res, Boston, MA USA

Tonkin, AM:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

Zheng, JZ:
 Hong Kong Univ Sci & Technol Guangzhou, Biosci & Biomed Engn Thrust, Syst Hub, Guangzhou, Guangdong, Peoples R China

 Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou, Peoples R China

Nelson, MR:
 Univ Tasmania, Menzies Inst Med Res, Hobart, Australia

Neumann, JT:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

 Univ Heart & Vasc Ctr UHZ, Dept Cardiol, Hamburg, Germany

 German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany

Woods, RL:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

Tran, C:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

Schutte, AE:
 Univ New South Wales, George Inst Global Hlth, Sch Populat Hlth, Sydney, Australia

Pandey, A:
 Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX USA

Chen, LY:
 Univ Minnesota, Lillehei Heart Inst, Med Sch, Cardiovasc Div, Minneapolis, MN USA

 Univ Minnesota, Med Sch, Dept Med, Cardiovasc Div, Minneapolis, MN USA

Liu, L:
 Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China

Mcneil, JJ:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia

Beilin, L:
 Univ Western Australia, Med Sch, Perth, Australia

Tes, HF:
 Univ Hong Kong, Sch Clin Med, Dept Med, Hong Kong, Peoples R China

Parati, G:
 Univ Milano Bicocca, Dept Med & Surg, Milan, Italy

 Dept Univ Milano Bicocca Cardiol, San Luca Hosp, Ist Auxol Italiano, IRCCS, Milan, Italy

Zhou, Z:
 Monash Univ, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
ISSN: 00097322





Circulation
Editorial
Lippincott Williams & Wilkins Ltd., TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 152 Número: 23
Páginas: 1621-1633
WOS Id: 001630780900006
ID de PubMed: 41122849
imagen Green Submitted

MÉTRICAS